Virbac SA (VRBCF)

USD 339.23

(0.0%)

Net Income Summary of Virbac SA

  • Virbac SA's latest annual net income in 2023 was 121.29 Million EUR , down -0.55% from previous year.
  • Virbac SA's latest quarterly net income in 2024 Q2 was 47.33 Million EUR , down 0.0% from previous quarter.
  • Virbac SA reported an annual net income of 121.96 Million EUR in 2022, up 7.78% from previous year.
  • Virbac SA reported an annual net income of 113.16 Million EUR in 2021, down -16.82% from previous year.
  • Virbac SA reported a quarterly net income of 47.33 Million EUR for 2024 Q2, down 0.0% from previous quarter.
  • Virbac SA reported a quarterly net income of 121.29 Million EUR for 2023 FY, down -0.55% from previous quarter.

Annual Net Income Chart of Virbac SA (2023 - 2002)

Historical Annual Net Income of Virbac SA (2023 - 2002)

Year Net Income Net Income Growth
2023 121.29 Million EUR -0.55%
2022 121.96 Million EUR 7.78%
2021 113.16 Million EUR -16.82%
2020 136.03 Million EUR 163.9%
2019 51.55 Million EUR 156.48%
2018 20.09 Million EUR 880.54%
2017 -2.57 Million EUR -107.43%
2016 34.64 Million EUR 268.38%
2015 9.4 Million EUR -85.21%
2014 63.59 Million EUR 5.08%
2013 60.52 Million EUR -9.16%
2012 66.62 Million EUR 15.84%
2011 57.51 Million EUR -9.3%
2010 63.41 Million EUR 63.37%
2009 38.81 Million EUR 9.62%
2008 35.4 Million EUR 14.06%
2007 31.04 Million EUR 24.6%
2006 24.91 Million EUR 25.83%
2005 19.79 Million EUR 18.37%
2004 16.72 Million EUR -39.28%
2003 27.54 Million EUR -30.76%
2002 39.78 Million EUR 0.0%

Peer Net Income Comparison of Virbac SA

Name Net Income Net Income Difference
AstraZeneca PLC 5.95 Billion USD 97.963%
Bristol-Myers Squibb Company PFD CONV 2 8.02 Billion USD 98.488%
CSPC Pharmaceutical Group Limited 830.91 Million USD 85.402%
Clarus Therapeutics Holdings, Inc. -56.51 Million USD 314.641%
Novartis AG 14.85 Billion USD 99.183%
PT Kalbe Farma Tbk. 179.7 Million USD 32.502%